Nova News
THETA EDGE AND NOVA FORMS JOINT VENTURE COMPANY
5 Sep 2023 – Nova has signed a landmark agreement with Theta Edge Berhad to establish a joint venture company to jointly market and implement state-of-the-art e-government solutions as well as a full range of IT services including system integration, consultancy and infrastructure system services in Malaysia. Nova MSC’s Executive Director, Mr Nazerollnizam Bin Kasim, said: “We are immensely proud…
EYRIS SELENA+ APPROVED FOR USE IN AUSTRALIA
21 Aug 2023 – We are thrilled to share that EyRIS has achieved a significant milestone by receiving TGA (Therapeutic Goods Administration) approval for the use of SELENA+ in Australia. This achievement underscores our commitment to detect retinal diseases and ultimately eliminate preventable blindness through early treatment on a global scale. A pivotal aspect of this achievement is our strategic…
NOVA USHERS IN TRANSFORMATIVE GROWTH STRATEGY WITH APPOINTMENT OF TWO NEW BOARD MEMBERS
26 Jun 2023 – Nova MSC Berhad (“NovaMSC” or “the Group”), a leading provider of software development and engineering solutions, is pleased to announce the appointment of Dato’ Adriana Law (below left) and Nazerollnizam Kasim (below right) as members of its Board of Directors. NovaMSC’s Executive Chairman, Mr Loh Guan Huat Sunny, warmly welcomed the new directors and said, “We…
EYRIS FORMS TRI-PARTITE PARTNERSHIP TO BRING SELENA+ TO TANZANIA
7 June 2023 – EyRIS is thrilled to be selected to participate in a ground-breaking tripartite partnership with The International Centre for Eye Health at the London School of Hygiene and Tropical Medicine, University of London and Tanzanian Ministry of Health. This collaboration aims to validate the use of Artificial Intelligence in screening for diabetic retinopathy (DR) in low-resource settings….
SAO RAFAEL HOSPITAL, BRAZIL POWERS SCREENING USING AI TECHNOLOGY
5 June 2023 – EyRIS is thrilled to announce our collaboration with Sao Rafael Hospital which is part of the renowned Rede D’Or São Luiz healthcare network in Brazil. This partnership underlines Rede D’Or São Luiz’s determination in improving patient care through state-of-the-art AI technology. By leveraging on SELENA+’s proven algorithms, Rede D’Or São Luiz aims to expand screening and…
SELENA+ IN ANOTHER COMMUNITY OUTREACH PROGRAM
2 June 2023 – EyRIS participated in another community outreach program, this time jointly organized by the Singapore Buddhist Youth Mission Temple and Diabetes Singapore, under the tagline “Healthiness is a Blessing”, aptly on Vesak Day. Worshippers were given the opportunity health check and experince EyRIS latest seamless workflow, which captures the fundus image and return the SELENA+ results of…
EYRIS AND OPTOMETRIST WAREHOUSE JOIN FORCES TO ADVANCE HEALTHCARE WITH AI-DRIVEN DIABETIC RETINOPATHY SCREENING
1 June 2023 – EyRIS, a pioneering company in artificial intelligence (AI) healthcare solutions, and Optometrist Warehouse, part of the Chemist Warehouse Group in Australia, have signed a Memorandum of Understanding (MOU) to collaborate on a ground-breaking study focused on the effectiveness of AI in screening diabetic retinopathy. This collaboration marks a significant milestone in the field of healthcare, showcasing…
NOVA FEATURES LATEST HEALTHCARE INNOVATIONS AT APHM 2023
Jun 2023 – NOVA MSC Berhad, together with our partner Theta Edge Berhad had a successful 3-day event from 30 May – 1 June at the APHM (Association of Private Hospitals Malaysia) International Healthcare Conference & Exhibition 2023, Kuala Lumpur. Organised under the apt theme, “New Dynamics in Delivery of Healthcare” to address this ever changing milieu of healthcare delivery,…
SELENA+ RECEIVES REGULATORY APPROVAL FROM MINISTRY OF HEALTH & PREVENTION, UAE
May 2023 – We are thrilled to announce that SELENA+ has successfully attained regulatory approval from the Ministry of Health & Prevention, United Arab Emirates (UAE). market At nearly 19%, UAE has one of the world’s highest rates of diabetes. With diabetes comes complications such as diabetes retinopathy (DR) which left untreated can lead to blindness. It is well-documented that…
EYRIS SIGNS PARTNERSHIP WITH VUNO
May 2023 – EyRIS is excited to announce our partnership with VUNO which supplies VUNO Med-Fundus AI, a complimentary AI solution used for detection of 12 fundus abnormalities. This innovation promises to contribute to a holistic AI offering on the EyRIS platform. This strategic partnership between VUNO and EyRIS brings value to the eye screening community as it provides an…
SELENA+ JOURNEY FEATURED PHYSICIAN SCIENTIST SUMMIT IN JORDAN
4 May 2023 – Aqaba Medical Sciences University (AMSU) and Jordan Medical Association (JMA) jointly organised the inaugural Physician Scientist Summit which serves as an important congregation of stakeholders in the scientific medical research landscape – providing collaborative opportunities, scientific tools and knowledge to Jordanian physicians at all levels. It is the country’s largest medical scientific gathering. EyRIS is proud…
PANAGA HEALTH CHOOSES VESALIUS
Apr 2023 – Panaga Health Centre (PHC), Brunei Darussalam opened in 1968 to provide quality medical and health services to the employees of Brunei Shell Petroleum (BSP) along with their dependents and also the public. Primarily, PHC is a primary health centre that operates emergency services together with ancillary departments such as laboratory, diagnostic imaging and occupational health. To improve…